1
|
Turchetta A, Moodie EEM, Stephens DA, Savy N, Moodie Z. The time-dependent Poisson-gamma model in practice: Recruitment forecasting in HIV trials. Contemp Clin Trials 2024; 144:107607. [PMID: 38908745 DOI: 10.1016/j.cct.2024.107607] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2024] [Revised: 05/20/2024] [Accepted: 06/12/2024] [Indexed: 06/24/2024]
Abstract
Despite a growing body of literature in the area of recruitment modeling for multicenter studies, in practice, statistical models to predict enrollments are rarely used and when they are, they often rely on unrealistic assumptions. The time-dependent Poisson-Gamma model (tPG) is a recently developed flexible methodology which allows analysts to predict recruitments in an ongoing multicenter trial, and its performance has been validated on data from a cohort study. In this article, we illustrate and further validate the tPG model on recruitment data from randomized controlled trials. Additionally, in the appendix, we provide a practical and easy to follow guide to its implementation via the tPG R package. To validate the model, we show the predictive performance of the proposed methodology in forecasting the recruitment process of two HIV vaccine trials conducted by the HIV Vaccine Trials Network in multiple Sub-Saharan countries.
Collapse
Affiliation(s)
- Armando Turchetta
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Armando Turchetta and Erica Moodie: 2001 McGill College Ave, Montreal, H3A 1Y7 Quebec, Canada.
| | - Erica E M Moodie
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Armando Turchetta and Erica Moodie: 2001 McGill College Ave, Montreal, H3A 1Y7 Quebec, Canada
| | - David A Stephens
- Department of Mathematics and Statistics, McGill University, David Stephens: 805 Sherbrooke St W, Montreal, H3A 2K6 Quebec, Canada
| | - Nicolas Savy
- Toulouse Mathematics Institute, University of Toulouse III, Nicolas Savy: 118 Rte de Narbonne, 31400, Toulouse, France
| | - Zoe Moodie
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Zoe Moodie: 1100 Fairview Ave. N. P.O. Box 19024. Seattle, WA 98109-1024, USA
| |
Collapse
|
2
|
Heesen P, Roos M. Freely accessible software for recruitment prediction and recruitment monitoring of clinical trials: A systematic review. Contemp Clin Trials Commun 2024; 39:101298. [PMID: 38689828 PMCID: PMC11059437 DOI: 10.1016/j.conctc.2024.101298] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2024] [Revised: 04/12/2024] [Accepted: 04/21/2024] [Indexed: 05/02/2024] Open
Abstract
Background The successful completion of clinical trials ultimately depends on realistic recruitment predictions. Statistical methods for recruitment prediction implemented in a free-of-charge open-source software could be routinely used by researchers worldwide to design clinical trials. However, the availability of such software implementations is currently unclear. Methods Two independent reviewers conducted a systematic review following PRISMA guidelines. Eligible articles included English publications focused on statistical methods for recruitment prediction and monitoring that referred to software implementations. The list of articles retrieved from well-established data bases was enriched by backtracking of references provided by eligible articles. The current software availability and open-source status were tabulated. Results We found 21 eligible articles, 7 of which (33 %) provide freely accessible software. Ultimately, only one article provides a link to an easy-to-comprehend, well-documented, and currently directly applicable free-of-charge open-source software. The lack of availability is mainly caused by blocked access and outdated links. Conclusions While several software implementations exist for recruitment prediction, only a small fraction is freely accessible. These results highlight the need for future efforts to achieve free access to well-documented software implementations supporting researchers in routinely using statistical methods to arrive at realistic recruitment predictions in clinical trials.
Collapse
Affiliation(s)
- Philip Heesen
- Faculty of Medicine, University of Zurich, Raemistrasse 71, 8006, Zurich, Switzerland
| | - Malgorzata Roos
- Department of Biostatistics at the Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, 8001, Zurich, Switzerland
| |
Collapse
|
3
|
Zhong S, Xing Y, Yu M, Wang L. Enrollment forecast for clinical trials at the portfolio planning phase based on site-level historical data. Pharm Stat 2024; 23:151-167. [PMID: 37871925 DOI: 10.1002/pst.2343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2023] [Revised: 09/05/2023] [Accepted: 09/25/2023] [Indexed: 10/25/2023]
Abstract
An accurate forecast of a clinical trial enrollment timeline at the planning phase is of great importance to both corporate strategic planning and trial operational excellence. The naive approach often calculates an average enrollment rate from historical data and generates an inaccurate prediction based on a linear trend with the average rate. Under the traditional framework of a Poisson-Gamma model, site activation delays are often modeled with either fixed initiation time or a simple random distribution while incorporating the user-provided site planning information to achieve good forecast accuracy. However, such user-provided information is not available at the early portfolio planning stage. We present a novel statistical approach based on generalized linear mixed-effects models and the use of non-homogeneous Poisson processes through the Bayesian framework to model the country initiation, site activation, and subject enrollment sequentially in a systematic fashion. We validate the performance of our proposed enrollment modeling framework based on a set of 25 preselected studies from four therapeutic areas. Our modeling framework shows a substantial improvement in prediction accuracy in comparison to the traditional statistical approach. Furthermore, we show that our modeling and simulation approach calibrates the data variability appropriately and gives correct coverage rates for prediction intervals of various nominal levels. Finally, we demonstrate the use of our approach to generate the predicted enrollment curves through time with confidence bands overlaid.
Collapse
Affiliation(s)
- Sheng Zhong
- Statistical Innovation Group, Data and Statistical Sciences, AbbVie Inc., North Chicago, Illinois, USA
| | - Yunzhao Xing
- Statistical Innovation Group, Data and Statistical Sciences, AbbVie Inc., North Chicago, Illinois, USA
| | - Mengjia Yu
- Statistical Innovation Group, Data and Statistical Sciences, AbbVie Inc., North Chicago, Illinois, USA
| | - Li Wang
- Statistical Innovation Group, Data and Statistical Sciences, AbbVie Inc., North Chicago, Illinois, USA
| |
Collapse
|
4
|
Yu M, Zhong S, Xing Y, Wang L. Enrollment Forecast for Clinical Trials at the Planning Phase with Study-Level Historical Data. Ther Innov Regul Sci 2024; 58:42-52. [PMID: 37713098 DOI: 10.1007/s43441-023-00564-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2023] [Accepted: 07/24/2023] [Indexed: 09/16/2023]
Abstract
Given progressive developments and demands on clinical trials, accurate enrollment timeline forecasting is increasingly crucial for both strategic decision-making and trial execution excellence. Naïve approach assumes flat rates on enrollment using average of historical data, while traditional statistical approach applies simple Poisson-Gamma model using time-invariant rates for site activation and subject recruitment. Both of them are lack of non-trivial factors such as time and location. We propose a novel two-segment statistical approach based on Quasi-Poisson regression for subject accrual rate and Poisson process for subject enrollment and site activation. The input study-level data are publicly accessible and it can be integrated with historical study data from user's organization to prospectively predict enrollment timeline. The new framework is neat and accurate compared to preceding works. We validate the performance of our proposed enrollment model and compare the results with other frameworks on 7 curated studies.
Collapse
Affiliation(s)
- Mengjia Yu
- Statistical Innovation Group, Data and Statistical Sciences, AbbVie Inc., 1 N Waukegan Rd, North Chicago, IL, USA
| | - Sheng Zhong
- Statistical Innovation Group, Data and Statistical Sciences, AbbVie Inc., 1 N Waukegan Rd, North Chicago, IL, USA.
| | - Yunzhao Xing
- Statistical Innovation Group, Data and Statistical Sciences, AbbVie Inc., 1 N Waukegan Rd, North Chicago, IL, USA
| | - Li Wang
- Statistical Innovation Group, Data and Statistical Sciences, AbbVie Inc., 1 N Waukegan Rd, North Chicago, IL, USA.
| |
Collapse
|
5
|
Shipes VB, Meinzer C, Wolf BJ, Li H, Carpenter MJ, Kamel H, Martin RH. Designing a phase-III time-to-event clinical trial using a modified sample size formula and Poisson-Gamma model for subject accrual that accounts for the lag in site initiation using the PERT distribution. Stat Med 2023; 42:5694-5707. [PMID: 37926516 PMCID: PMC10847961 DOI: 10.1002/sim.9935] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2021] [Revised: 07/01/2023] [Accepted: 10/03/2023] [Indexed: 11/07/2023]
Abstract
A priori estimation of sample size and subject accrual in multi-site, time-to-event clinical trials is often challenging. Such trials are powered based on the number of events needed to detect a clinically significant difference. Sample size based on number of events relates to the expected duration of observation time for each subject. Temporal patterns in site initiation and subject enrollment ultimately affect when subjects can be accrued into the study. Lag times are common as the site start-up process optimizes, resulting in delays that may curtail observational follow-up and therefore undermine power. The proposed method introduces a Program Evaluation and Review Technique (PERT) model into the sample size estimation which accounts for the lag in site start-up. Additionally, a PERT model is introduced into a Poisson-Gamma subject accrual model to predict the quantity of study sites needed. The introduction of the PERT model provides greater flexibility in both a priori power assessment and planning the number of sites, as it specifically allows for the inclusion of anticipated delays in site start-up time. This model results in minimal power loss even when PERT distribution inputs are misspecified compared to the traditional assumption of simultaneous start-up for all sites. Together these updated formulations for sample size and subject accrual models offer an improved method for designing a multi-site time-to-event clinical trial that accounts for a flexible site start-up process.
Collapse
Affiliation(s)
- Virginia B Shipes
- Division of Biostatistics, Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA
- Biostatistics, The Emmes Company, Rockville, Maryland, USA
| | - Caitlyn Meinzer
- Division of Biostatistics, Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA
| | - Bethany J Wolf
- Division of Biostatistics, Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA
| | - Hong Li
- Division of Biostatistics, Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA
| | - Mathew J Carpenter
- Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA
- Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA
| | - Hooman Kamel
- Department of Neurology, Weill Cornell Medicine, New York City, New York, USA
| | - Renee H Martin
- Division of Biostatistics, Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA
| |
Collapse
|
6
|
Turchetta A, Savy N, Stephens DA, Moodie EEM, Klein MB. A time-dependent Poisson-Gamma model for recruitment forecasting in multicenter studies. Stat Med 2023; 42:4193-4206. [PMID: 37491664 DOI: 10.1002/sim.9855] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2022] [Revised: 07/04/2023] [Accepted: 07/14/2023] [Indexed: 07/27/2023]
Abstract
Forecasting recruitments is a key component of the monitoring phase of multicenter studies. One of the most popular techniques in this field is the Poisson-Gamma recruitment model, a Bayesian technique built on a doubly stochastic Poisson process. This approach is based on the modeling of enrollments as a Poisson process where the recruitment rates are assumed to be constant over time and to follow a common Gamma prior distribution. However, the constant-rate assumption is a restrictive limitation that is rarely appropriate for applications in real studies. In this paper, we illustrate a flexible generalization of this methodology which allows the enrollment rates to vary over time by modeling them through B-splines. We show the suitability of this approach for a wide range of recruitment behaviors in a simulation study and by estimating the recruitment progression of the Canadian Co-infection Cohort.
Collapse
Affiliation(s)
- Armando Turchetta
- Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada
| | - Nicolas Savy
- Toulouse Mathematics Institute, University of Toulouse III, Toulouse, France
| | - David A Stephens
- Department of Mathematics and Statistics, McGill University, Montral, Quebec, Canada
| | - Erica E M Moodie
- Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada
| | - Marina B Klein
- Department of Medicine, Division of Infectious Diseases/Chronic Viral Illness Service, McGill University Health Center, Montreal, Quebec, Canada
| |
Collapse
|
7
|
Perperoglou A, Zhang Y, Kipourou DK. Modeling time-varying recruitment rates in multicenter clinical trials. Biom J 2023; 65:e2100377. [PMID: 36287068 DOI: 10.1002/bimj.202100377] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2021] [Revised: 07/06/2022] [Accepted: 07/20/2022] [Indexed: 08/04/2023]
Abstract
Multicenter phase II/III clinical trials are large-scale operations that often include hundreds of recruiting centers in several countries. Therefore, the operational aspects of a trial must be thoroughly planned and closely monitored to ensure better oversight and study conduct. Predicting patient recruitment plays a pivotal role in trial monitoring as it informs how many people are expected to be recruited on a given day. As such, study teams may rely on predictions to assess progress and detect any deviations from the original plan that might put the study and potentially, patients at risk. Recruitment predictions are often based on a Poisson-Gamma model that assumes that centers have a constant recruitment rate throughout the trial. The model has useful features and has extensively been used, yet its main assumption is often unrealistic. A nonhomogeneous Poisson process has been recently proposed that can incorporate time-varying recruitment rates. In this work, we predict patient recruitment using both approaches and assess the impact of said assumption in a real-world setting where studies may not necessarily have constant center-specific recruitment rates. The paper showcases experience from modeling recruitment in trials sponsored by AstraZeneca between 2005 and 2018. In these data, there is evidence of time-varying recruitment rates. The predictive performance of models that account for both constant and time-varying recruitment effects is presented. Following a descriptive analysis of data, we assess model performance and investigate the impact of model misspecification.
Collapse
Affiliation(s)
- Aris Perperoglou
- Human-Centered AI & ML, Digital Health, R&D, AstraZeneca, Cambridge, UK
| | - Youyi Zhang
- Advanced Analytics, Data Science & AI, AstraZeneca, Cambridge, UK
| | | |
Collapse
|
8
|
Zhang X, Huang B. A simple and robust model for enrollment projection in clinical trials. Contemp Clin Trials 2022; 123:106999. [PMID: 36371001 DOI: 10.1016/j.cct.2022.106999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2022] [Revised: 11/04/2022] [Accepted: 11/06/2022] [Indexed: 11/11/2022]
Abstract
Enrollment projection in clinical trials is a topic gaining attention in the statistics literature in recent years. A number of methods have been proposed in this area. Some approaches are sophisticated but complicated to implement. We aim to implement a simple and robust empiric Bayes Poisson Gamma model (PGM) that is suitable for practical use. We assume a constant and site-specific underlying enrollment rate over time, which comes from a common Gamma distribution. Choice of prior parameters is data driven. We tested the proposed PGM in a simulation study as well as a number of oncology trials with various enrollment patterns, which yield satisfactory results. Compared to a flexible nonparametric model (Zhang and Long, 2010), the PGM is associated with a narrower credible interval as a result of parametric assumptions. However, the model prediction may be off when the assumptions are substantially violated.
Collapse
Affiliation(s)
- Xiaoxi Zhang
- Statistics, Pfizer Inc., New York, NY, United States of America.
| | - Bo Huang
- Statistics, Pfizer Inc., New York, NY, United States of America
| |
Collapse
|
9
|
Wang L, Liu Y, Chen X, Pulkstenis E. Real time monitoring and prediction of time to endpoint maturation in clinical trials. Stat Med 2022; 41:3596-3611. [PMID: 35587584 DOI: 10.1002/sim.9436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2021] [Revised: 04/29/2022] [Accepted: 05/02/2022] [Indexed: 11/05/2022]
Abstract
In clinical trials, almost all key milestone dates can be defined in terms of time to endpoint maturation (TTEM). The real time monitoring and accurate prediction of TTEM have a significant impact on clinical trial planning and execution and can bring significant value to clinical trial practitioners. TTEM is defined as the time to achieve or observe a certain number or percentage of some endpoint of interest. It is a combination of time to site initiation, time to subject enrollment after site initiation and time to event of interest after subject enrollment. To better predict TTEM during the trial, the future site initiation and subject enrollment have to be taken into account while predicting the number of events. In this article, we propose a novel simulation-based framework combining time to site initiation, time to subject enrollment and time to event in order to predict TTEM. A nonhomogeneous Poisson process with a quadratic time-varying rate function is used to model site initiation and subject enrollment and more advanced time to event models had been explored and integrated on top of them, such as Weibull, piecewise exponential, and model averaging which is equivalent to a Bayesian model selection strategy. To evaluate the predictive performance of the proposed methodology, we conducted extensive simulations and applied the methodology to 14 randomly selected real oncology phase 2 and phase 3 studies in both solid tumor and hematology with a total 31 study-endpoint combinations. The predictive performance of the proposed methodology was then compared with popular and commonly available commercial software, for example, East (Cytel, Cambridge, MA, USA). From both simulation and real data, the proposed methodology can significantly improve the prediction accuracy by up to 54% compared to the commonly available method.
Collapse
Affiliation(s)
- Li Wang
- Data and Statistical Sciences, AbbVie Inc., North Chicago, Illinois, USA
| | - Yang Liu
- Data and Statistical Sciences, AbbVie Inc., North Chicago, Illinois, USA
| | - Xiaotian Chen
- Data and Statistical Sciences, AbbVie Inc., North Chicago, Illinois, USA
| | - Erik Pulkstenis
- Data and Statistical Sciences, AbbVie Inc., North Chicago, Illinois, USA
| |
Collapse
|
10
|
Bieganek C, Aliferis C, Ma S. Prediction of clinical trial enrollment rates. PLoS One 2022; 17:e0263193. [PMID: 35202402 PMCID: PMC8870517 DOI: 10.1371/journal.pone.0263193] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2021] [Accepted: 01/13/2022] [Indexed: 11/18/2022] Open
Abstract
Clinical trials represent a critical milestone of translational and clinical sciences. However, poor recruitment to clinical trials has been a long standing problem affecting institutions all over the world. One way to reduce the cost incurred by insufficient enrollment is to minimize initiating trials that are most likely to fall short of their enrollment goal. Hence, the ability to predict which proposed trials will meet enrollment goals prior to the start of the trial is highly beneficial. In the current study, we leveraged a data set extracted from ClinicalTrials.gov that consists of 46,724 U.S. based clinical trials from 1990 to 2020. We constructed 4,636 candidate predictors based on data collected by ClinicalTrials.gov and external sources for enrollment rate prediction using various state-of-the-art machine learning methods. Taking advantage of a nested time series cross-validation design, our models resulted in good predictive performance that is generalizable to future data and stable over time. Moreover, information content analysis revealed the study design related features to be the most informative feature type regarding enrollment. Compared to the performance of models built with all features, the performance of models built with study design related features is only marginally worse (AUC = 0.78 ± 0.03 vs. AUC = 0.76 ± 0.02). The results presented can form the basis for data-driven decision support systems to assess whether proposed clinical trials would likely meet their enrollment goal.
Collapse
Affiliation(s)
- Cameron Bieganek
- Institute for Health Informatics, University of Minnesota, Minneapolis, MN, United States of America
| | - Constantin Aliferis
- Institute for Health Informatics, University of Minnesota, Minneapolis, MN, United States of America
- Department of Medicine, University of Minnesota, Minneapolis, MN, United States of America
| | - Sisi Ma
- Institute for Health Informatics, University of Minnesota, Minneapolis, MN, United States of America
- Department of Medicine, University of Minnesota, Minneapolis, MN, United States of America
| |
Collapse
|
11
|
Spies R, Siegfried N, Myers B, Grobbelaar SS. Concept and development of an interactive tool for trial recruitment planning and management. Trials 2021; 22:189. [PMID: 33676535 PMCID: PMC7936448 DOI: 10.1186/s13063-021-05112-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2020] [Accepted: 02/09/2021] [Indexed: 11/10/2022] Open
Abstract
Background Predicting and monitoring recruitment in large, complex trials is essential to ensure appropriate resource management and budgeting. In a novel partnership between clinical trial investigators of the South African Medical Research Council and industrial engineers from the Stellenbosch University Health Systems Engineering and Innovation Hub, we developed a trial recruitment tool (TRT). The objective of the tool is to serve as a computerised decisions-support system to aid the planning and management phases of the trial recruitment process. Method The specific requirements of the TRT were determined in several workshops between the partners. A Poisson process simulation model was formulated and incorporated in the TRT to predict the recruitment duration. The assumptions underlying the model were made in consultation with the trial team at the start of the project and were deemed reasonable. Real-world data extracted from a current cluster trial, Project MIND, based in 24 sites in South Africa was used to verify the simulation model and to develop the monitoring component of the TRT. Results The TRT comprises a planning and monitoring component. The planning component generates different trial scenarios for predicted trial recruitment duration based on user inputs, e.g. number of sites, initiation delays. The monitoring component uses and analyses the data retrieved from the trial management information system to generate different levels of information, displayed visually on an interactive, user-friendly dashboard. Users can analyse the results at trial or site level, changing input parameters to see the resultant effect on the duration of trial recruitment. Conclusion This TRT is an easy-to-use tool that assists in the management of the trial recruitment process. The TRT has potential to expedite improved management of clinical trials by providing the appropriate information needed for the planning and monitoring of the trial recruitment phase. This TRT extends prior tools describing historic recruitment only to using historic data to predict future recruitment. The broader project demonstrates the value of collaboration between clinicians and engineers to optimise their respective skillsets. Supplementary Information The online version contains supplementary material available at 10.1186/s13063-021-05112-z.
Collapse
Affiliation(s)
- Ruan Spies
- Department of Industrial Engineering, Stellenbosch University, Joubert Street, Stellenbosch, 7600, South Africa.
| | - Nandi Siegfried
- Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Francie van Zyl Drive, Tygerberg, Cape Town, 7505, South Africa
| | - Bronwyn Myers
- Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Francie van Zyl Drive, Tygerberg, Cape Town, 7505, South Africa
| | - Sara S Grobbelaar
- Department of Industrial Engineering, Stellenbosch University, Joubert Street, Stellenbosch, 7600, South Africa
| |
Collapse
|
12
|
Mountain R, Sherlock C. Recruitment prediction for multicenter clinical trials based on a hierarchical Poisson-gamma model: Asymptotic analysis and improved intervals. Biometrics 2021; 78:636-648. [PMID: 33604911 DOI: 10.1111/biom.13447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2020] [Revised: 01/08/2021] [Accepted: 02/05/2021] [Indexed: 11/30/2022]
Abstract
We analyze predictions of future recruitment to a multicenter clinical trial based on a maximum-likelihood fitting of a commonly used hierarchical Poisson-gamma model for recruitments at individual centers. We consider the asymptotic accuracy of quantile predictions in the limit as the number of recruitment centers grows large and find that, in an important sense, the accuracy of the quantiles does not improve as the number of centers increases. When predicting the number of further recruits in an additional time period, the accuracy degrades as the ratio of the additional time to the census time increases, whereas when predicting the amount of additional time to recruit a further n • + patients, the accuracy degrades as the ratio of n • + to the number recruited up to the census period increases. Our analysis suggests an improved quantile predictor. Simulation studies verify that the predicted pattern holds for typical recruitment scenarios in clinical trials and verify the much improved coverage properties of prediction intervals obtained from our quantile predictor. In the process of extending the applicability of our methodology, we show that in terms of the accuracy of all integer moments it is always better to approximate the sum of independent gamma random variables by a single gamma random variable matched on the first two moments than by the moment-matched Gaussian available from the central limit theorem.
Collapse
Affiliation(s)
- Rachael Mountain
- Department of Mathematics and Statistics, Lancaster University, Lancaster, UK
| | - Chris Sherlock
- Department of Mathematics and Statistics, Lancaster University, Lancaster, UK
| |
Collapse
|
13
|
Urbas S, Sherlock C, Metcalfe P. Interim recruitment prediction for multi-center clinical trials. Biostatistics 2020; 23:485-506. [PMID: 32978616 PMCID: PMC9007446 DOI: 10.1093/biostatistics/kxaa036] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2020] [Revised: 08/11/2020] [Accepted: 08/15/2020] [Indexed: 11/12/2022] Open
Abstract
Summary
We introduce a general framework for monitoring, modeling, and predicting the recruitment to multi-center clinical trials. The work is motivated by overly optimistic and narrow prediction intervals produced by existing time-homogeneous recruitment models for multi-center recruitment. We first present two tests for detection of decay in recruitment rates, together with a power study. We then introduce a model based on the inhomogeneous Poisson process with monotonically decaying intensity, motivated by recruitment trends observed in oncology trials. The general form of the model permits adaptation to any parametric curve-shape. A general method for constructing sensible parameter priors is provided and Bayesian model averaging is used for making predictions which account for the uncertainty in both the parameters and the model. The validity of the method and its robustness to misspecification are tested using simulated datasets. The new methodology is then applied to oncology trial data, where we make interim accrual predictions, comparing them to those obtained by existing methods, and indicate where unexpected changes in the accrual pattern occur.
Collapse
Affiliation(s)
- Szymon Urbas
- STOR-i Centre for Doctoral Training, Lancaster University, Lancaster, UK
| | - Chris Sherlock
- Department of Mathematics and Statistics, Lancaster University, Lancaster, UK
| | | |
Collapse
|
14
|
Hu H, Wang L, Li C, Ge W, Wu K, Xia J. Modelling the patient accrual with truncated Gaussian mixture distribution for the accurate estimation of sample size in survival trials. Stat Methods Med Res 2020; 29:2972-2987. [PMID: 32281472 DOI: 10.1177/0962280220913891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
In survival trials with fixed trial length, the patient accrual rate has a significant impact on the sample size estimation or equivalently, on the power of trials. A larger sample size is required for the staggered patient entry. During enrollment, the patient accrual rate changes with the recruitment publicity effect, disease incidence and many other factors and fluctuations of the accrual rate occur frequently. However, the existing accrual models are either over-simplified for the constant rate assumption or complicated in calculation for the subdivision of the accrual period. A more flexible accrual model is required to represent the fluctuant patient accrual rate for accurate sample size estimation. In this paper, inspired by the flexibility of the Gaussian mixture distribution in approximating continuous densities, we propose the truncated Gaussian mixture distribution accrual model to represent different variations of accrual rate by different parameter configurations. The sample size calculation formula and the parameter setting of the proposed accrual model are discussed further.
Collapse
Affiliation(s)
- Haixia Hu
- Department of Health Statistics, Faculty of Preventive Medicine, Air Force Medical University, Xi'an, China
| | - Ling Wang
- Department of Health Statistics, Faculty of Preventive Medicine, Air Force Medical University, Xi'an, China
| | - Chen Li
- Department of Health Statistics, Faculty of Preventive Medicine, Air Force Medical University, Xi'an, China
| | - Wei Ge
- Department of Health Statistics, Faculty of Preventive Medicine, Air Force Medical University, Xi'an, China
| | - Kejian Wu
- Department of Mathematics and Physics, School of Basic Medicine, Air Force Medical University, Xi'an, China *The first two authors contributed equally to this work
| | - Jielai Xia
- Department of Health Statistics, Faculty of Preventive Medicine, Air Force Medical University, Xi'an, China
| |
Collapse
|
15
|
Gkioni E, Dodd S, Rius R, Gamble C. Statistical models to predict recruitment in clinical trials were rarely used by statisticians in UK and European networks. J Clin Epidemiol 2020; 124:58-68. [PMID: 32229249 DOI: 10.1016/j.jclinepi.2020.03.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2019] [Revised: 03/04/2020] [Accepted: 03/23/2020] [Indexed: 11/25/2022]
Abstract
OBJECTIVE Identify the current practice for recruitment prediction and monitoring within clinical trials. STUDY DESIGN AND SETTING Chief investigators (CIs) were surveyed to identify data sources and adjustments made to support recruitment prediction. Statisticians were surveyed to determine methods and adjustments used when predicting and monitoring recruitment. Participants were identified from the National Institute for Health Research recently funded studies, the UK Clinical Research Collaboration registered Clinical Trial Units network or by the European Clinical Research Infrastructure Network. RESULTS A total of 51 CIs (UK = 32, ECRIN = 19) and 104 statisticians (UK = 51, ECRIN = 53) were contacted. Response rates varied (CIs UK = 53% ECRIN = 32%; statisticians UK = 98% ECRIN = 36%). Multiple data sources are used to support recruitment rates, most commonly audit data from multiple sites. Variation in individual site recruitment rates are frequently incorporated, but staggered site openings were featured more commonly among UK respondents. Simple prediction methods are preferred to rarely used statistical models. Lack of familiarity with statistical methods are barriers to their use with evidence needed to justify the time required to support their implementation. CONCLUSION Simplistic methods will continue as the mainstay of prediction; however, generation of evidence supporting the benefits of complex statistical models should promote their implementations. Multiple data sources to support recruitment prediction are being used, and further work on the quality of these data is needed. Pressure to be optimistic about recruitment rates for the trial to be attractive to funders was felt by a sizable minority.
Collapse
Affiliation(s)
- Efstathia Gkioni
- Department of Biostatistics, University of Liverpool, A Member of Liverpool Health Partners, Liverpool, UK; Université de Paris, CRESS, INSERM, INRA, F-75004 Paris, France.
| | - Susanna Dodd
- Department of Biostatistics, University of Liverpool, A Member of Liverpool Health Partners, Liverpool, UK
| | - Roser Rius
- Department of Statistics and Operations Research, School of Mathematics and Statistics, BarcelonaTech (UPC), Barcelona, Spain
| | - Carrol Gamble
- Department of Biostatistics, University of Liverpool, A Member of Liverpool Health Partners, Liverpool, UK
| |
Collapse
|